Literature DB >> 9361268

Transcription factors in normal and neoplastic pituitary tissues.

R V Lloyd1, R Y Osamura.   

Abstract

Transcription factors are proteins that bind to regulatory elements in DNA and have critical roles in gene regulation during development, in cellular growth and differentiation. The four major groups of transcription factors have been classified according to the motif in the DNA-binding domains and include: (1) the helix-turn-helix group, which includes the Pit-1/GHF-1 (Pit-1) transcription factor; (2) the zing finger group, which includes estrogen and other steroid hormone receptors; (3) the leucine zipper group, which includes c-fos protooncogene, and (4) the helix-loop-helix group, which includes the c-myc oncogene. Members of all four groups have been described in normal and neoplastic anterior pituitary gland tissues. Pit-1 has been shown to regulate prolactin (PRL), growth hormone (GH), and thyroid-stimulating hormone (TSH) cells during development and differentiation. Genetic defects in this transcription factor have led to specific diseases in rodents and humans such as dwarfism and cretinism. Estrogen receptor (ER) protein plays a critical role in the regulation of gene expression in some anterior pituitary cells. There is a differential distribution of ER in anterior pituitary cells and tumors; PRL, gonadotroph, and null cell tumors are the principal adenomas expressing ER. The protooncogene c-fos is regulated by estrogen in various tissues, linking the regulation of one transcription factor by another transcription factor with a different motif. The c-myc oncogene has been detected in the pituitary gland and in some pituitary tumors, although the exact role of this oncogene in pituitary tumor development is uncertain. Because of the critical role that transcription factors play in pituitary cell development and differentiation, we can anticipate many more studies to elucidate their many functions in normal and neoplastic pituitary tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361268     DOI: 10.1002/(SICI)1097-0029(19971015)39:2<168::AID-JEMT8>3.0.CO;2-H

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  12 in total

Review 1.  Practical markers used in the diagnosis of neuroendocrine tumors.

Authors:  Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 2.  Advances and controversies in the classification and grading of pituitary tumors.

Authors:  E R Laws; D L Penn; C S Repetti
Journal:  J Endocrinol Invest       Date:  2018-06-01       Impact factor: 4.256

3.  Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors.

Authors:  Yudo Ishii; Masanori Suzuki; Susumu Takekoshi; Noboru Egashira; Michio Yamazaki; Shunsuke Miyai; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 4.  Role of transcription factors in the pathogenesis of pituitary adenomas: a review.

Authors:  A Suhardja; K Kovacs; J Rutka
Journal:  J Neurooncol       Date:  2001-12       Impact factor: 4.130

Review 5.  Classification of pituitary adenomas.

Authors:  K Kovacs; E Horvath; S Vidal
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

6.  Cdx2 as a marker for neuroendocrine tumors of unknown primary sites.

Authors:  Lori A Erickson; Bettina Papouchado; Haytham Dimashkieh; Shuya Zhang; Nobuki Nakamura; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

7.  Immunolocalization of Pit-1 in gonadotroph nuclei is indicative of the transdifferentiation of gonadotroph to lactotroph cells in prolactinomas induced by estrogen.

Authors:  Jorge Humberto Mukdsi; Ana Lucía De Paul; Sonia Muñoz; Agustín Aoki; Alicia Inés Torres
Journal:  Histochem Cell Biol       Date:  2004-06-09       Impact factor: 4.304

8.  Diethylstilbestrol increases the density of prolactin cells in male mouse pituitary by inducing proliferation of prolactin cells and transdifferentiation of gonadotropic cells.

Authors:  Keiko Shukuwa; Shin-Ichi Izumi; Yoshitaka Hishikawa; Kuniaki Ejima; Satoshi Inoue; Masami Muramatsu; Yasuyoshi Ouchi; Takashi Kitaoka; Takehiko Koji
Journal:  Histochem Cell Biol       Date:  2006-02-09       Impact factor: 4.304

Review 9.  Overview of the 2017 WHO Classification of Pituitary Tumors.

Authors:  Ozgur Mete; M Beatriz Lopes
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

Review 10.  Update on pituitary adenomas in the 2017 World Health Organization classification: innovations and perspectives.

Authors:  George Kontogeorgos
Journal:  Hormones (Athens)       Date:  2021-01-16       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.